Found 7 presentations matching your search
Nash- updated guidelines, new criterias, new inclusions
Recent advances in the pharmacotherapy of Non-Alcoholic Steatohepatitis (NASH) have made significant...
Nafld
Chair and Presenter Rohit Loomba, MD, MHSc, and Alina M. Allen, MD, MS, discuss metabolic dysfunctio...
GLP-1 obesity
THIS PPT GIVES AN IDEA ABOUT PHARMACOLOGICAL SCREENING METHODS.PHARMACOLOGICAL SCREENING MODELS PHAR...
Chair and Presenter, Arun J. Sanyal, MBBS, MD, discusses metabolic dysfunction–associated steatohe...